Home » Pipeline
Pipeline
| Company | Drug/Device | Medical Condition | Status |
|---|---|---|---|
| Novatek Pharmaceuticals | TQ Formula | oral treatment for COVID-19 patients in an outpatient setting | IND approved by the FDA |
| Occlutech | Flex II PFO occluder | patients with cryptogenic stroke | Investigational Device Exemption approved by the FDA |
| Angel Pharmaceuticals | CPI-818 | relapsed/refractory T-cell lymphomas | IND approved by the China National Medical Products Administration |
| Enlivex Therapeutics | Allocetra | treatment of patients with severe and critical COVID-19 experiencing acute respiratory distressed syndrome | authorization granted by the Israeli Ministry of Health for a phase 2b trial |
| Istari Oncology | PVSRIPO | head and neck squamous-cell carcinoma | initiation of phase 1/2 substudy |
| Turning Point Therapeutics | repotrectinib in combination with trametinib | RAS G12D-mutated advanced solid tumors | initiation of phase 1b/2 trial |
| Trigone Pharma | TRG-100 | interstitial cystitis/ bladder pain syndrome | initiation of phase 2 trial |
| Cali Biosciences | CPL-01 (extended-release injectable ropivacaine hydrochloride) | long-acting postoperative analgesic | initiation of phase 2b trial |
| Pfizer-BioNTech | COVID-19 Vaccine | COVID-19 | Emergency Use Authorization (EUA) amended to include an additional shot in certain immunocompromised people |
| Moderna | COVID-19 Vaccine | COVID-19 | EUA amended to include an additional shot in certain immunocompromised people |
| Spectrum Solutions | SDNA-1000 saliva collection device | at-home COVID-19 testing | EUA amended to include the unsupervised self-collection of saliva |
| Eli Lilly | Lyumjev (insulin lispro-aabc injection) subcutaneous pump | glycemic control in adults with type 1 and type 2 diabetes | approved by the FDA for expanded administration |
| GlaxoSmithKline | Jemperli (dostarlimab) | adults with dMMR recurrent or advanced solid tumors | approved by the FDA for expanded indication |
| Jazz Pharmaceuticals | Xywav (calcium, magnesium, potassium and sodium oxybates) oral solution | idiopathic hypersomnia | approved by the FDA for new indication |
| Merck | Welireg (belzutifan) | treatment of adult patients with certain types of Von Hippel-Lindau disease-associated tumors | approved by the FDA |
| Pfizer | Ticovac tick-borne encephalitis (TBE) vaccine | active immunization to prevent TBE in individuals age one year and older | approved by the FDA |
| GC Pharma | GreenGene F (beroctocog alfa) recombinant human coagulation factor VIII for injection | control and prophylaxis of bleeding episodes in patients with hemophilia A | approved in China |
| Nasus Pharma | Taffix intranasal powder | viral infections | approved in Spain |
| Photocure | Hexvix (hexaminolevulinate HCl) | management of bladder cancer | approved in Chile |
Upcoming Events
-
25May
-
28Jun
-
16Oct
